<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The <z:e sem="disease" ids="C0740302" disease_type="Disease or Syndrome" abbrv="">5q-syndrome</z:e> has been recognized as a distinct subtype of <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>) with characteristic clinical and pathologic features </plain></SENT>
<SENT sid="1" pm="."><plain>Nevertheless, the definition of this syndrome is imprecise </plain></SENT>
<SENT sid="2" pm="."><plain>To better understand how the <z:e sem="disease" ids="C0740302" disease_type="Disease or Syndrome" abbrv="">5q-syndrome</z:e> is related to other "5q- only" myeloid disorders, we searched our conventional cytogenetics file for cases with 5q- as the sole karyotypic abnormality </plain></SENT>
<SENT sid="3" pm="."><plain>31 cases of "5q- only" myeloid disorders were found, and they were <z:hpo ids='HP_0005505'>refractory anemia</z:hpo> (n = 16), <z:hpo ids='HP_0005505'>refractory anemia</z:hpo> with excess blasts (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">RAEB</z:e>) (n = 5), <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">RAEB</z:e> in transformation (n = 1), <z:hpo ids='HP_0011010'>chronic</z:hpo> myelomonocytic <z:hpo ids='HP_0001909'>leukemia</z:hpo> (n = 1) and <z:hpo ids='HP_0004808'>acute myeloid leukemia</z:hpo> (n = 8) </plain></SENT>
<SENT sid="4" pm="."><plain>They included 15 men and 16 women, with a median age of 67 years (range, 40-84 years) </plain></SENT>
<SENT sid="5" pm="."><plain>The marrow blast count was &lt; or = 11% in 22 cases and &gt; or = 25% in the remaining nine cases </plain></SENT>
<SENT sid="6" pm="."><plain>The following morphologic features were common in the marrow: megakaryocytic hypolobation (30/31, 97%), <z:hpo ids='HP_0012133'>erythroid hypoplasia</z:hpo> (26/31, 84%), basophilia (19/31, 62%) and <z:hpo ids='HP_0001880'>eosinophilia</z:hpo> (16/31, 52%) </plain></SENT>
<SENT sid="7" pm="."><plain>Of those with &lt; or = 11% blasts, 7/22 cases met the criteria of the <z:e sem="disease" ids="C0740302" disease_type="Disease or Syndrome" abbrv="">5q-syndrome</z:e>, as defined by high mean corpuscle volume (MCV), <z:mpath ids='MPATH_458'>normal</z:mpath>/high platelet counts, and megakaryocytic hypolobation </plain></SENT>
<SENT sid="8" pm="."><plain>Except for the two defining parameters for the <z:e sem="disease" ids="C0740302" disease_type="Disease or Syndrome" abbrv="">5q-syndrome</z:e> (MCV and platelet count), there was no significant difference in hematologic parameters between the <z:e sem="disease" ids="C0740302" disease_type="Disease or Syndrome" abbrv="">5q-syndrome</z:e> and other cases with &lt; or = 11% blasts </plain></SENT>
<SENT sid="9" pm="."><plain>Furthermore, no significant difference in the chromosomal breakpoints or survival was found between these two groups </plain></SENT>
<SENT sid="10" pm="."><plain>We conclude that "5q- only" <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> show consistent morphologic features, suggesting a common pathogenesis related to their similar cytogenetic abnormality </plain></SENT>
<SENT sid="11" pm="."><plain>In "5q- only" <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> with &lt; or = 11% marrow blasts, strict application of the conventional criteria of the <z:e sem="disease" ids="C0740302" disease_type="Disease or Syndrome" abbrv="">5q-syndrome</z:e> may not be necessary in predicting the overall prognosis </plain></SENT>
</text></document>